Select Publications
Conference Abstracts
, 2022, 'Changing landscape of lung cancer survival in a regional Australian centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 160 - 160
, 2022, 'Geriatric assessment (GA) in the instagram era: Adding photographs to electronic ga to enhance supportive care (ESC) of older adults with cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 224 - 224
, 2022, 'Stigma and ageism - The challenges of delivering appropriate care to older adults with NSCLC', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 105 - 105
, 2021, 'Durability of response to immune checkpoint inhibitors (ICI) in metastatic Merkel cell carcinoma (mMCC) after treatment cessation.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 39, pp. 9543 - 9543, http://dx.doi.org/10.1200/jco.2021.39.15_suppl.9543
, 2021, 'Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903)', in Gynecologic Oncology, Vol. 161, pp. 160 - 165, http://dx.doi.org/10.1016/j.ygyno.2021.02.016
, 2020, 'MONARCC: A randomized phase II study of panitumumab monotherapy and panitumumab (pan) plus 5 Fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer (mCRC): An AGITG clinical trial', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 38, presented at Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, CA, San Francisco, 23 January 2020 - 25 January 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530922700257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Exercise and androgen deprivation therapy: Current practice and future direction at a regional cancer centre', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide, pp. 198 - 198, presented at 2019 COSA 46th Annual Scientific Meeting, Adelaide, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13263
, 2019, 'Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 37, pp. 3072 - 3072, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3072
, 2017, 'INCORPORATING GERI-ONCOLOGY ASSESSMENTS IN GU RESEARCH', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 13, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427541700040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Preprints
, Association between Antihypertensive Medicine Use and Risk of Ovarian Cancer in Women Aged 50 Years and Older, http://dx.doi.org/10.2139/ssrn.4414764
, DNA sequencing and gene-expression profiling assists in making a tissue of origin diagnosis in cancer of unknown primary, http://dx.doi.org/10.1101/2022.06.24.22276729
, Whole genome sequencing improves tissue of origin diagnosis and treatment options for cancer of unknown primary, http://dx.doi.org/10.1101/2024.08.09.24311642